Ranibizumab - Global Market Updates

Health

Lupin Completes Phase 3 Trials for Lucentis Biosimilar

John - August 6, 2024 0

Lupin Limited announced the successful completion of global Phase 3 trials for its Lucentis (ranibizumab) biosimilar, LUBT010. This trial, involving 600 patients from India,...

Narendra Modi Congratulates Paetongtarn Shinawatra on Election as Thai Prime Minister

John - August 18, 2024

Cabinet Approves Pradhan Mantri Awas Yojana-Urban 2.0 to Build 1 Crore Homes

John - August 10, 2024

Tata Power Solar Teams Up with ICICI Bank to Make Solar Energy More Affordable

John - August 23, 2024

Samsung Unveils The Premiere 9 and 7 Projectors With Cutting-Edge Laser Technology

Clara Bennett - August 26, 2024

Tag: Ranibizumab

Lupin Completes Phase 3 Trials for Lucentis Biosimilar

EDITOR PICKS

Narendra Modi Congratulates Paetongtarn Shinawatra on Election as Thai Prime Minister

Cabinet Approves Pradhan Mantri Awas Yojana-Urban 2.0 to Build 1 Crore Homes

Tata Power Solar Teams Up with ICICI Bank to Make Solar Energy More Affordable

Samsung Unveils The Premiere 9 and 7 Projectors With Cutting-Edge Laser Technology

EVEN MORE NEWS

Samsung Food+ Upgrades AI-Powered Features for Smarter, Healthier Cooking at IFA...

NVIDIA Launches AI-Driven NIM Agent Blueprint to Revolutionize Drug Discovery

Samsung Partners With Qualcomm to Enhance In-Vehicle Infotainment Systems

POPULAR CATEGORY